Unresectable Locally Recurrent Breast Cancer Clinical Trials

ReadTheTrial indexes 1 studies for Unresectable Locally Recurrent Breast Cancer. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Unresectable Locally Recurrent Breast Cancer.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials for Unresectable Locally Recurrent Breast Cancer

A Randomized, Open-Label, Multicenter Phase II Clinical Study of Different Doses of Trastuzumab Rezetecan for Injection or Trastuzumab Deruxtecan for Injection in the Treatment of Unresectable Locally Recurrent/Metastatic Breast Cancer With HR-Positive and HER2-Low Expression

NCT07497386 · NOT YET RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Unresectable Locally Recurrent Breast Cancer?

There are 1 clinical trials listed for Unresectable Locally Recurrent Breast Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Unresectable Locally Recurrent Breast Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Unresectable Locally Recurrent Breast Cancer trials in?

Current Unresectable Locally Recurrent Breast Cancer trials are distributed across: Phase 2 (1).

Find More Trials